| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.89B | +29.5% |
| Cost of Revenue | $2.42B | +34.9% |
| Gross Profit | $1.47B | +21.5% |
| R&D Expense | $78.5M | +18.8% |
| SG&A Expense | $773.8M | +25.6% |
| Operating Income | $616.8M | +17.0% |
| Pre-tax Income | $550.0M | +28.1% |
| Income Tax | $121.5M | -35.5% |
| Net Income | $710.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $471.9M | +31.0% |
| Current Assets | $1.64B | +18.0% |
| Total Assets | $6.85B | +1.7% |
| Current Liabilities | $1.00B | +25.2% |
| Long-term Debt | $1.56B | -27.6% |
| Total Liabilities | $3.12B | -10.7% |
| Stockholders' Equity | $3.73B | +15.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $465.2M | -27.7% |
| Capital Expenditures | $93.3M | +26.1% |
| Investing Cash Flow | $520.8M | +168.7% |
| Financing Cash Flow | -$968.4M | -762.4% |
| Free Cash Flow | $371.9M | -34.7% |
| +114.0% |
| EPS (Basic) | $4.36 | +118.0% |
| EPS (Diluted) | $4.31 | +118.8% |